Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Ensuring the Success of Phage Therapy: Identifying and Characterizing Antiphage Defence in the Human and Aquacultural Pathogen Vibrio parahaemolyticus

FY 2022-23

Summary
Antibiotic resistance is on the rise, generating "superbugs" or infections which cannot be treated through traditional antibiotic therapy. As such, researchers are pursuing alternative treatments. One such alternative treatment is phage therapy, the use of viruses that infect bacteria to treat bacterial infections without causing harm to their human host. However, like antibiotic resistance, bacteria have a number of defences against phage infection, called antiphage defence. Many researchers have spent considerable time and talent developing phage therapy and isolating bacteriophages that infect disease causing microbes. However, for some bacterial diseases, little is understood about how the bacteria resist phage infection, which considerably threatens the success of phage therapy. One such bacteria is V. parahaemolyticus, a bacteria which finds a home inside of oysters. When contaminated oysters are eaten raw, V. parahaemolyticus can cause a diarrheal disease in humans, which is generally quite mild. However, with the advent of climate change, more dangerous strains of V. parahaemolyticus are emerging, threatening human health and the aquaculture industry. This work will use innovative new technologies, as well as tried-and-true molecular biology methods, to identify and characterize how various strains of V. parahaemolyticus defend themselves from phage infection. In doing so, we can better understand and predict how this organism might resist phage therapy efforts, and can build better phage therapy. Bacteria have evolved excellent defences against natural infection, which threatens our offensive treatment efforts. If we can predict these defences, we will have much better success at managing bacterial infections when antibiotics are no longer effective. Perhaps most importantly, successful phage therapy efforts mean that we can prevent and treat infections in Canadians and prevent economic loss to the Canadian aquaculture industry.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472056
Name
Getz Landon J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Ensuring the Success of Phage Therapy: Identifying and Characterizing Antiphage Defence in the Human and Aquacultural Pathogen Vibrio parahaemolyticus
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antiphage Defence; Novel Therapeutics; Pandemic And Emerging Pathogens; Phage Therapy; Seafood-Borne Diarrhea; Vibrio Parahaemolyticus
Abstract
Antibiotic resistance is on the rise, generating "superbugs" or infections which cannot be treated through traditional antibiotic therapy. As such, researchers are pursuing alternative treatments. One such alternative treatment is phage therapy, the use of viruses that infect bacteria to treat bacterial infections without causing harm to their human host. However, like antibiotic resistance, bacteria have a number of defences against phage infection, called antiphage defence. Many researchers have spent considerable time and talent developing phage therapy and isolating bacteriophages that infect disease causing microbes. However, for some bacterial diseases, little is understood about how the bacteria resist phage infection, which considerably threatens the success of phage therapy. One such bacteria is V. parahaemolyticus, a bacteria which finds a home inside of oysters. When contaminated oysters are eaten raw, V. parahaemolyticus can cause a diarrheal disease in humans, which is generally quite mild. However, with the advent of climate change, more dangerous strains of V. parahaemolyticus are emerging, threatening human health and the aquaculture industry. This work will use innovative new technologies, as well as tried-and-true molecular biology methods, to identify and characterize how various strains of V. parahaemolyticus defend themselves from phage infection. In doing so, we can better understand and predict how this organism might resist phage therapy efforts, and can build better phage therapy. Bacteria have evolved excellent defences against natural infection, which threatens our offensive treatment efforts. If we can predict these defences, we will have much better success at managing bacterial infections when antibiotics are no longer effective. Perhaps most importantly, successful phage therapy efforts mean that we can prevent and treat infections in Canadians and prevent economic loss to the Canadian aquaculture industry.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Getz, Landon J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2022-23) | Canada Spends